An international study has identified 11 new gene alterations connected to more aggressive prostate cancer using a simple blood test. The discovery could improve treatments for prostate cancer by ...

A group of scientists from the University of Surrey have shared findings from a seven-year research study, revealing that a new approach could be on the horizon for treating one of the most prevalent ...

BioNTech has announced it will acquire UK AI start-up InstaDeep in a deal worth up to £562m, following the company’s initial equity investment as part of InstaDeep’s Series B financing round in ...

Merck & Co is closing on a new indication for its checkpoint inhibitor Keytruda in early bladder cancer in the US, following a positive vote by an FDA expert panel. The Oncologic Drugs Advisory ...

Merck KGaA and Pfizer have staked a claim to the first-line renal cell carcinoma market, with data on a new combination that analyst say could challenge to become a new standard for the disease. The ...

The European Commission (EC) has approved Roche’s highly anticipated haemophilia treatment Hemlibra (emicizumab). The rare bleeding disorder treatment, which is cleared in the EU for routine ...

A new COVID-19 subvariant, XBB.1.5, is causing concern in the US, where it has been spreading rapidly since December. Data from the US Centers for Disease Control and Prevention (CDC) has estimated ...

The American Medical Association (AMA) has urged the US Food and Drug Administration (FDA) to work with the medical community to provide transparency around COVID-19 vaccines currently in development.

The US Food and Drug Administration’s (FDA) Cellular, Tissue and Gene Therapies Advisory Committee have completed its meeting for CRISPR Therapeutics and Vertex Pharmaceuticals’ exagamglogene ...

The European Union is demanding that AstraZeneca (AZ) delivers 120 million doses of its COVID-19 vaccine by the end of June, threatening financial sanctions if the company fails to meet this target.

Healthcare communications network McCann Health has announced the promotion of Adriano Botter (pictured above) to global chief digital officer. Prior to taking on the new role, Botter was digital ...

Gilead has posted its results for the first quarter of 2021, noting an increase in revenues for the quarter, driven by its COVID-19 pill Veklury, while sales of its HIV drugs took a hit. The total ...